ICANLonline

Final Reports: Demonstrating The Overall
Quality Of The Nuclear Medicine Facility


from the September 2004 issue

Evaluation of the final report is considered by many to be the most important part of the accreditation process because it demonstrates the overall quality of the nuclear medicine facility in question. Upon reviewing information submitted for accreditation, ICANL Board members and application reviewers identify a wide variety of reporting deficiencies. Report deficiencies remain the most frequent issue for delay in accreditation. Commonly seen deficient nuclear medicine reports range from those lacking final impressions or stress details, to those void of a specific purpose for which the test is being performed or a description of the radiopharmaceutical and its dose. Regardless of the specific deficiency, poor quality final reports provide little or no value to the referring physician and, in many unfortunate cases, lead to inappropriate clinical management decisions.

As stated by Frans J. Th. Wackers, MD, PhD, ICANL President, in his book Nuclear Cardiology, The Basics: "The referring physician is entitled to a clear conclusion: normal or abnormal, and if abnormal, how severely abnormal. The report may indicate, when appropriate, whether the risk for future cardiac events is low, moderate, or high. Certain imaging findings may have different clinical implications depending on the clinical context and results of stress testing. These nuances should be conveyed in an optimal report. If there were technical limitations to the study, they need to be stated and their impact on the final interpretation indicated."

The American Society of Nuclear Cardiology's Consensus Statement entitled "Reporting of Radionuclide Myocardial Perfusion Imaging Studies" is available online at www.asnc.org/resources/reporting_rmp_imaging.pdf. Written to serve as a standard for all nuclear cardiology laboratories, this document, published in August 2003, identifies the critical factors involved in effective reporting.

The ICANL Standards include specific guidelines for final reports. The goal of these guidelines is not to force all accredited laboratories to produce identical, "canned" reports, but rather to ensure that a complete interpretation of the results of the examination is readily available to anyone in the health care community who may be involved in the care of the patient.

The necessary content of the final report, as outlined in the Standards, Part II, Section 6.3, includes, but is not limited to:

A. Patient's name, gender, age and identification number, if applicable

B. Requesting health care provider's name

C. Date of the examination

D. Date of the report

E. Clinical indications leading to the performance of the examination

F. An adequate description of the procedure performed. The description must include the type of the examination(s). It must also include the type, amount and route of administration of any radioactive or non-radioactive material administered. The type of stress, if applicable, must be described.

G. An overview of the results of the examination including pertinent positive and negative findings. Where appropriate, this will include localization and quantification of abnormal findings, including stress test findings, if applicable.

H. The reasons for limited examinations and/or deviations from standard protocols, if applicable

I. An overall succinct impression

J. Any need for additional studies based on the interpretation of the nuclear cardiology procedures

K. Identification and manual or electronic signature of responsible physician

In some cases, the content and format of the report itself are acceptable; however, issues with timeliness of the report's dissemination are to blame for resulting suboptimal patient care. Acceptable timeframes for reporting are addressed in the Standards, Part II, Section 6.1.1 as follows:

6.1.1

All diagnostic procedures must be reviewed promptly after the study is completed as appropriate for the risk of clinical significant results. Reports of examinations should be:

A. Interpreted and prepared within one working day.

B. Signed by the interpreting physician within two working days after completion of the examination and forwarded to the referring health care provider.

Visit the ICANL website at www.icanl.org/icanl/apply/sampledocs.htm to download templates for an Exercise Spect Report, an ERNA report, and a Vasodilator/Adrenergic Stress Spect Myocardial Perfusion Imaging Report.


Top of Page

 

Online
Accreditation

Log In Here

EXISTING APPLICANTS
Already have a User ID and Password?
Access your account here.


NEW APPLICANTS
New to Online Accreditation? Get started here.

<< Back to News

JOIN THE NEWSLETTER MAILING LIST!
Submit your request form to receive future issues of the ICANL Newsletter.

THE NEWSLETTER ARCHIVE
Now you can also view this article within the ICANL Newsletter in which it was first published.

September 2004 (3.3 mb)


All newsletters open using the free Adobe Reader or any previous version of Adobe Acrobat Reader. If not already installed on your computer, download the Adobe Reader.

ICAVLonline ICAELonline ICAMRLonline ICACTLonline
Copyright 1997-2008 ICANL, 8830 Stanford Boulevard, Suite 306, Columbia, MD 21045. All rights reserved.